Chlorthenoxazine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C10H10ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KA0B657LV3, chemically known as 4-oxo-2-(beta-chloroethyl)-2,3-dihydrobenzo-1,3-oxazine but generally known as chlorthenoxazine, which bears US NIH Compound Identifier 8602. European Medicines Agency schedules Chlorthenoxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06214MIG. The term CHLORTHENOXAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). CHLORTHENOXAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorthenoxazine under HS 29349990 and SITC 51579. As of Q4 2014, CHLORTHENOXAZINE remains the US FDA Preferred Term for this commodity. Chlorthenoxazine bears US NLM identifiers UMLS ID CL386772 and NCI Concept Code C77339. SMILES: C1=CC=C2C(=C1)C(=O)NC(O2)CCCL.